- Home
- ONCY vs PGZ Comparison
ONCY vs PGZ Comparison
Compare ONCY & PGZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ONCY
- PGZ
- Stock Information
- Founded
- ONCY 1998
- PGZ 2012
- Country
- ONCY Canada
- PGZ United States
- Employees
- ONCY N/A
- PGZ N/A
- Industry
- ONCY Pharmaceuticals and Biotechnology
- PGZ Investment Managers
- Sector
- ONCY Health Care
- PGZ Finance
- Exchange
- ONCY Nasdaq
- PGZ Nasdaq
- Market Cap
- ONCY 86.1M
- PGZ 71.0M
- IPO Year
- ONCY 1999
- PGZ N/A
- Fundamental
- Price
- ONCY $0.98
- PGZ $10.39
- Analyst Decision
- ONCY Strong Buy
- PGZ
- Analyst Count
- ONCY 2
- PGZ 0
- Target Price
- ONCY $4.00
- PGZ N/A
- AVG Volume (30 Days)
- ONCY 386.7K
- PGZ 23.0K
- Earning Date
- ONCY 11-12-2024
- PGZ 01-01-0001
- Dividend Yield
- ONCY N/A
- PGZ 12.26%
- EPS Growth
- ONCY N/A
- PGZ N/A
- EPS
- ONCY N/A
- PGZ N/A
- Revenue
- ONCY N/A
- PGZ N/A
- Revenue This Year
- ONCY N/A
- PGZ N/A
- Revenue Next Year
- ONCY N/A
- PGZ N/A
- P/E Ratio
- ONCY N/A
- PGZ N/A
- Revenue Growth
- ONCY N/A
- PGZ N/A
- 52 Week Low
- ONCY $0.84
- PGZ $8.46
- 52 Week High
- ONCY $1.75
- PGZ $10.59
- Technical
- Relative Strength Index (RSI)
- ONCY 36.89
- PGZ 29.74
- Support Level
- ONCY $1.01
- PGZ $10.61
- Resistance Level
- ONCY $1.15
- PGZ $10.72
- Average True Range (ATR)
- ONCY 0.06
- PGZ 0.14
- MACD
- ONCY -0.03
- PGZ -0.03
- Stochastic Oscillator
- ONCY 3.14
- PGZ 5.08
About ONCY Oncolytics Biotech Inc.
Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatment. The other projects in the company's pipeline include, Bracelet-1 for treatment of Breast Cancer, Goblet cohort-1, Goblet cohort-5 for treatment of Gastro-Intestinal Cancer among others.
About PGZ Principal Real Estate Income Fund of Beneficial Interest
Principal Real Estate Income Fund is a non-diversified, closed-end management investment company. Its investment objective is to provide high current income with capital appreciation by investing in commercial real estate-related securities.